Merve Esra Çıtar DAZIROĞLU, Yasemin AKDEVELİOĞLU

Oral Kontraseptif Kullanımının Sağlık ve Serum Mikro Besin Ögesi Seviyeleri Üzerine Etkisi

Dünya genelinde, doğurganlık çağındaki kadınlar tarafından yaygın bir şekilde kullanılan oral kontraseptifler (OK), doğumkontrolünün yanı sıra birtakım hastalıkların tedavisi amacı ile de tercih edilebilmektedir. Piyasada ilk tanıtıldığı 1960yılından bu yana OK’lerin içeriğinde, başta östrojen dozunun azaltılması olmak üzere pek çok değişiklik yapılmış ve buşekilde olası yan etkilerin azaltılması amaçlanmıştır. Bununla birlikte, günümüz OK’lerinin kullanımında da çeşitli sağlıkve beslenme sorunları devam etmektedir. Sağlık sorunlarının başında tromboembolizm ve bazı kanser türlerinin artışıgelmektedir. Beslenme konusunda, OK kullanan kadınlarda besin ögesi gereksinimlerinde değişiklik olup olmadığı kesinolarak bilinmediği için beslenmelerinde yapılacak değişiklikler konusu da net değildir. Bununla birlikte, OK kullanımının,başta B6 vitamini, B12 vitamini, C vitamini, folik asit ve çinko olmak üzere birçok mikro besin ögesi yetersizlikleri ileilişkili olduğu belirtilmektedir. Bu nedenle, OK kullanan kadınlarda da optimum sağlık için temel rol oynayan optimumbeslenmenin sağlanması, bu bireylerde erken dönemde alınacak önlemler ile mümkündür. OK kullanımına bağlı olasımikro besin ögesi yetersizliklerini önlemek için, beslenmenin değerlendirilmesi sonrasında, yeterli ve dengeli beslenmeninsağlanması veya gerekli olduğu takdirde hekim tavsiyesi ile besin takviyesi kullanımı, birinci basamakta çözüm önerisiolarak düşünülmelidir.

Effect of Oral Contraceptive Use on Health and Serum Micronutrient Levels

Oral contraceptives (OC), which are widely used by women of reproductive age worldwide, can be preferred for the purpose of treating certain diseases as well as birth control. Since the first time it was introduced in the market, many changes have been made in the content of OCs, especially in reducing the dosage of estrogen, and in this way, it is aimed to reduce the possible side effects; however, various health and nutrition problems continue in the use of OCs today. The most important of health problems are the increase in thromboembolism, some types of cancer. When nutritional problems are examined, it is not clear whether there is a change in nutritional requirements in women using OC, so it is not clear whether there will be changes in their diet. However, it is stated that the use of OC is associated with deficiencies of many micronutrients, especially vitamin B6 , vitamin B12, vitamin C, folic acid and zinc. Therefore, providing optimum nutrition, which plays a fundamental role for optimum health, is possible with early precautions in these individuals. In order to prevent possible micronutrient deficiencies, providing adequate and balanced nutrition after evaluation of nutrition or the use of food supplements with the recommendation of a physician should be considered as a first-line solution recommendation.

PDF

___

1. Cooper DB, Mahdy H. Oral contraceptive pills [Internet]. Treasure Island (FL): StatPearls Publishing; 2019, 8 p. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK430882/.
2. Golobof A, Kiley J. The current status of oral contraceptives: progress and recent innovations. Semin Reprod Med. 2016;34(3):145-51.
3. Bitzer J, Simon JA. Current issues and available options in combined hormonal contraception. Contraception. 2011;84(4):342-56.
4. Burkman RT, Collins JA, Shulman LP, Williams JK. Current perspectives on oral contraceptive use. Am J Obstet Gynecol. 2001;185(2):S4-S12.
5. Wakeman MP. A Review of the Effects of Oral Contraceptives on nutrient status, with especial consideration to folate in UK. J Adv Med Med Res. 2019:1-17.
6. Lussana F, Zighetti ML, Bucciarelli P, Cugno M, Cattaneo M. Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users. TThromb. Res. 2003;112(1-2):37-41.
7. Cahill L, Corey PN, El-Sohemy A. Vitamin C deficiency in a population of young Canadian adults. Am. J. Epidemiol. 2009;170(4):464-71.
8. Shere M, Bapat P, Nickel C, Kapur B, Koren G. Association between use of oral contraceptives and folate status: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2015;37(5):430-8.
9. Akinloye O, Adebayo T, Oguntibeju OO, Oparinde D, Ogunyemi E. Effects of contraceptives on serum trace elements, calcium and phosphorus levels. W Indian Med J. 2011;60(3):308-15.
10. Park B, Kim J. Oral contraceptive use, micronutrient deficiency, and obesity among premenopausal females in Korea: The necessity of dietary supplements and food intake improvement. PloS One. 2016;11(6):e0158177.
11. Colquitt CW, Martin TS. Contraceptive methods: A review of nonbarrier and barrier products. J. Pharm. Pract. 2017;30(1):130-5.
12. Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab. 2013;27(1):3-12.
13. Daniels K, Abma JC. Centers for Disease Control and Prevention (CDC). Current Contraceptive Status among Women Aged 15-49: United States, 2015-2017. NCHS Data Brief. 2018; 327.
14. Türkiye Beslenme ve Sağlık Araştırması (TBSA), T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 1132, Ankara, 2019.
15. Committee on Practice Bulletins—Gynecology. Noncontraceptive uses of hormonal contraceptives, ACOG Practice Bulletin No. 110. Obstetrics & Gynecology. 2010;115(1):206-18.
16. Caserta D, Ralli E, Matteucci E, Bordi G, Mallozzi M, Moscarini M. Combined oral contraceptives: health benefits beyond contraception. Panminerva Med. 2014;56(3):233-44.
17. Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol. 1999;180(6):S343-S8.
18. Peck R, Norris C. Significant risks of oral contraceptives (OCPs): Why this drug class should not be included in a preventive care mandate. Linacre Q. 2012;79(1):41-56.
19. Shufelt CL, Merz CNB. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53(3):221- 31.
20. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103(9):2394-400.
21. Kamp F, Rodrigues TSL, Donangelo CM. Effect of oral contraceptive use and zinc supplementation on zinc, iron and copper biochemical indices in young women. E Spen Eur E J Clin Nutr Metab. 2011;6(6):e253-e8.
22. Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003–2004. Am J Clin Nutr. 2008;87(5):1446-54.
23. Shojania AM, Wylie B. The effect of oral contraceptives on vitamin B12 metabolism. Am J Obstet Gynecol. 1979;135(1):129-34.
24. Wilson SM, Bivins BN, Russell KA, Bailey LB. Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status. Nutr. Rev. 2011;69(10):572-83.
25. Dante G, Vaiarelli A, Facchinetti F. Vitamin and mineral needs during the oral contraceptive therapy: A systematic review. Int J Reprod Contracept Obstet Gynecol. 2014;3(1):1-10.
26. Shojania AM. Oral contraceptives: effect of folate and vitamin B12 metabolism. Can. Med. Assoc. J. 1982;126(3):244.
27. Gardyn J, Mittelman M, Zlotnik J, Sela B, Cohen A. Oral contraceptives can cause falsely low vitamin B12 levels. Acta Haematol. 2000;104(1):22-4.
28. Streiff RR. Folate deficiency and oral contraceptives. JAMA. 1970;214(1):105-8.
29. Smith J, Goldsmith G, Lawrence J. Effects of oral contraceptive steroids on vitamin and lipid levels in serum. Am J Clin Nutr. 1975;28(4):371-6.
30. Zal F, Mostafavi-Pour Z, Amini F, Heidari A. Effect of vitamin E and C supplements on lipid peroxidation and GSH-dependent antioxidant enzyme status in the blood of women consuming oral contraceptives. Contraception. 2012;86(1):62-6.
31. Kuohung W, Borgatta L, Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidencebased analysis. Contraception. 2000;61(2):77-82.
32. Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density. Maturitas. 2006;54(2):176-80.
33. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani A. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporosis Int. 2000;11(6):544-8.
34. Zittermann A. Decreased urinary calcium loss and lower bone turnover in young oral contraceptive users. Metab. Clin. Exp. 2000;49(8):1078-82.
35. Milman N, Clausen J, Byg KE. Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol. 1998;77(1-2):13-9.
36. Fraser IS, Jensen J, Schaefers M, Mellinger U, Parke S, Serrani M. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest. Contraception. 2012;86(2):96-101.
37. Corbo MD, Lam J. Zinc deficiency and its management in the pediatric population: A literature review and proposed etiologic classification. J Am Acad Dermatol. 2013;69(4):616-24. e1.
38. Fallah S, Sani FV, Firoozrai M. Effect of contraceptive pill on the selenium and zinc status of healthy subjects. Contraception. 2009;80(1):40-3.
39. Mishu FA, Mia MAR, Ferdous N, Sarkar S. Study of serum zinc status in Bangladeshi women taking oral contraceptives. Birdem Med. J. 2020;10(1):12-5.
40. McCall KA, Huang C, Fierke CA. Function and mechanism of zinc metalloenzymes. Nutr. J. 2000;130(5):1437S-46S.